Duke Robotics (NASDAQ:DUKR – Get Free Report) and Mainz Biomed (NASDAQ:MYNZ – Get Free Report) are both small-cap industrials companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, institutional ownership, dividends, valuation and earnings.
Risk & Volatility
Duke Robotics has a beta of 2.23, indicating that its stock price is 123% more volatile than the S&P 500. Comparatively, Mainz Biomed has a beta of 0.31, indicating that its stock price is 69% less volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of current ratings and price targets for Duke Robotics and Mainz Biomed, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Duke Robotics | 1 | 0 | 1 | 0 | 2.00 |
| Mainz Biomed | 1 | 1 | 0 | 0 | 1.50 |
Duke Robotics presently has a consensus price target of $12.00, indicating a potential upside of 187.08%. Given Duke Robotics’ stronger consensus rating and higher possible upside, equities analysts plainly believe Duke Robotics is more favorable than Mainz Biomed.
Valuation and Earnings
This table compares Duke Robotics and Mainz Biomed”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Duke Robotics | $380,000.00 | 37.73 | -$1.24 million | ($0.67) | -6.24 |
| Mainz Biomed | $659,935.00 | 14.00 | -$21.65 million | ($65.60) | -0.02 |
Duke Robotics has higher earnings, but lower revenue than Mainz Biomed. Duke Robotics is trading at a lower price-to-earnings ratio than Mainz Biomed, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Duke Robotics and Mainz Biomed’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Duke Robotics | N/A | -146.36% | -86.13% |
| Mainz Biomed | N/A | N/A | N/A |
Summary
Duke Robotics beats Mainz Biomed on 7 of the 10 factors compared between the two stocks.
About Duke Robotics
Duke Robotics Corp (Nasdaq: DUKR) is a Fort Lauderdale, Florida–based company that develops advanced stabilization and autonomous robotic drone systems for both civilian and defense markets. On the civilian side, its Insulator Cleaning Drone (IC Drone) is a drone-enabled system for cleaning and monitoring high-voltage electric utility insulators, and its AEROTRACE platform uses AI-powered aerial monitoring to help infrastructure operators assess assets and prioritize maintenance. In defense, the company holds the intellectual property behind the Bird of Prey, a fully stabilized remote weapon system designed for non-line-of-sight and stand-off engagements, which is marketed by Elbit Systems Land Ltd. under the brand name Bird of Prey (formerly known as TIKAD).
About Mainz Biomed
Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States. The company offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. It also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. The company was founded in 2008 and is based in Mainz, Germany.
Receive News & Ratings for Duke Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Duke Robotics and related companies with MarketBeat.com's FREE daily email newsletter.
